159 related articles for article (PubMed ID: 22118419)
41. Accessing radiation response using hypoxia PET imaging and oxygen sensitive electrodes: a preclinical study.
Mortensen LS; Busk M; Nordsmark M; Jakobsen S; Theil J; Overgaard J; Horsman MR
Radiother Oncol; 2011 Jun; 99(3):418-23. PubMed ID: 21723634
[TBL] [Abstract][Full Text] [Related]
42. Measurement of Tumor Hypoxia in Patients With Locally Advanced Cervical Cancer Using Positron Emission Tomography with
Han K; Shek T; Vines D; Driscoll B; Fyles A; Jaffray D; Keller H; Metser U; Pintilie M; Xie J; Yeung I; Milosevic M
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1202-1209. PubMed ID: 29680257
[TBL] [Abstract][Full Text] [Related]
43. Investigation on tumor hypoxia in resectable primary prostate cancer as demonstrated by 18F-FAZA PET/CT utilizing multimodality fusion techniques.
Garcia-Parra R; Wood D; Shah RB; Siddiqui J; Hussain H; Park H; Desmond T; Meyer C; Piert M
Eur J Nucl Med Mol Imaging; 2011 Oct; 38(10):1816-23. PubMed ID: 21833840
[TBL] [Abstract][Full Text] [Related]
44. A prospective clinical study of ¹⁸F-FAZA PET-CT hypoxia imaging in head and neck squamous cell carcinoma before and during radiation therapy.
Servagi-Vernat S; Differding S; Hanin FX; Labar D; Bol A; Lee JA; Grégoire V
Eur J Nucl Med Mol Imaging; 2014 Aug; 41(8):1544-52. PubMed ID: 24570097
[TBL] [Abstract][Full Text] [Related]
45. Dual-tracer PET of viable tumor volume and hypoxia for identification of necrosis-containing radio-resistant Sub-volumes.
Busk M; Horsman MR; Overgaard J; Jakobsen S
Acta Oncol; 2019 Oct; 58(10):1476-1482. PubMed ID: 31432722
[No Abstract] [Full Text] [Related]
46. Dynamics of tumor hypoxia assessed by 18F-FAZA PET/CT in head and neck and lung cancer patients during chemoradiation: possible implications for radiotherapy treatment planning strategies.
Bollineni VR; Koole MJ; Pruim J; Brouwer CL; Wiegman EM; Groen HJ; Vlasman R; Halmos GB; Oosting SF; Langendijk JA; Widder J; Steenbakkers RJ
Radiother Oncol; 2014 Nov; 113(2):198-203. PubMed ID: 25434768
[TBL] [Abstract][Full Text] [Related]
47. A limited overlap between intratumoral distribution of 1-(5-fluoro-5-deoxy-α-D-arabinofuranosyl)-2-nitroimidazole and copper-diacetyl-bis[N(4)-methylthiosemicarbazone].
Furukawa T; Yuan Q; Jin ZH; Aung W; Yoshii Y; Hasegawa S; Endo H; Inoue M; Zhang MR; Fujibayashi Y; Saga T
Oncol Rep; 2015 Sep; 34(3):1379-87. PubMed ID: 26134305
[TBL] [Abstract][Full Text] [Related]
48. [
Nakajo M; Jinguji M; Tani A; Kajiya Y; Nandate T; Kitazano I; Yoshiura T
Mol Imaging Biol; 2020 Dec; 22(6):1609-1620. PubMed ID: 32651718
[TBL] [Abstract][Full Text] [Related]
49. Assessment of hypoxic subvolumes in laryngeal cancer with (18)F-fluoroazomycinarabinoside ((18)F-FAZA)-PET/CT scanning and immunohistochemistry.
Bruine de Bruin L; Bollineni VR; Wachters JE; Schuuring E; van Hemel BM; van der Wal JE; Slagter-Menkema L; de Bock GH; Steenbakkers RJ; Langendijk JA; Pruim J; van der Laan BF; Halmos GB
Radiother Oncol; 2015 Oct; 117(1):106-12. PubMed ID: 26250803
[TBL] [Abstract][Full Text] [Related]
50. The role of 18F-FAZA PET/CT in detecting lymph node metastases in renal cell carcinoma patients: a prospective pilot trial.
Capitanio U; Pepe G; Incerti E; Larcher A; Trevisani F; Lucianò R; Mapelli P; Bettinardi V; Monterisi C; Necchi A; Cascinu S; Bernardi R; Bertini R; Doglioni C; Gianolli L; Salonia A; Picchio M; Montorsi F
Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):554-560. PubMed ID: 32638098
[TBL] [Abstract][Full Text] [Related]
51. Cellular uptake of PET tracers of glucose metabolism and hypoxia and their linkage.
Busk M; Horsman MR; Jakobsen S; Bussink J; van der Kogel A; Overgaard J
Eur J Nucl Med Mol Imaging; 2008 Dec; 35(12):2294-303. PubMed ID: 18682937
[TBL] [Abstract][Full Text] [Related]
52. Synthesis of hypoxia imaging agent 1-(5-deoxy-5-fluoro-α-D-arabinofuranosyl)-2-nitroimidazole using microfluidic technology.
Bouvet VR; Wuest M; Wiebe LI; Wuest F
Nucl Med Biol; 2011 Feb; 38(2):235-45. PubMed ID: 21315279
[TBL] [Abstract][Full Text] [Related]
53. In Vivo Ester Hydrolysis as a New Approach in Development of Positron Emission Tomography Tracers for Imaging Hypoxia.
Zhang L; Yao X; Cao J; Hong H; Zhang A; Zhao R; Zhang Y; Zha Z; Liu Y; Qiao J; Zhu L; Kung HF
Mol Pharm; 2019 Mar; 16(3):1156-1166. PubMed ID: 30676751
[TBL] [Abstract][Full Text] [Related]
54. Mechanism-Specific Pharmacodynamics of a Novel Complex-I Inhibitor Quantified by Imaging Reversal of Consumptive Hypoxia with [
Gammon ST; Pisaneschi F; Bandi ML; Smith MG; Sun Y; Rao Y; Muller F; Wong F; De Groot J; Ackroyd J; Mawlawi O; Davies MA; Gopal YNV; Di Francesco ME; Marszalek JR; Dewhirst M; Piwnica-Worms D
Cells; 2019 Nov; 8(12):. PubMed ID: 31766580
[TBL] [Abstract][Full Text] [Related]
55. In Vivo Hypoxia PET Imaging Quantifies the Severity of Arthritic Joint Inflammation in Line with Overexpression of Hypoxia-Inducible Factor and Enhanced Reactive Oxygen Species Generation.
Fuchs K; Kuehn A; Mahling M; Guenthoer P; Hector A; Schwenck J; Hartl D; Laufer S; Kohlhofer U; Quintanilla-Martinez L; Reischl G; Röcken M; Pichler BJ; Kneilling M
J Nucl Med; 2017 May; 58(5):853-860. PubMed ID: 28183987
[TBL] [Abstract][Full Text] [Related]
56. Hypoxia imaging with
Melsens E; De Vlieghere E; Descamps B; Vanhove C; Kersemans K; De Vos F; Goethals I; Brans B; De Wever O; Ceelen W; Pattyn P
Radiat Oncol; 2018 Mar; 13(1):39. PubMed ID: 29514673
[TBL] [Abstract][Full Text] [Related]
57. 18F-EF5: a new PET tracer for imaging hypoxia in head and neck cancer.
Komar G; Seppänen M; Eskola O; Lindholm P; Grönroos TJ; Forsback S; Sipilä H; Evans SM; Solin O; Minn H
J Nucl Med; 2008 Dec; 49(12):1944-51. PubMed ID: 18997048
[TBL] [Abstract][Full Text] [Related]
58. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
59. Preclinical evaluation and validation of [18F]HX4, a promising hypoxia marker for PET imaging.
Dubois LJ; Lieuwes NG; Janssen MH; Peeters WJ; Windhorst AD; Walsh JC; Kolb HC; Ollers MC; Bussink J; van Dongen GA; van der Kogel A; Lambin P
Proc Natl Acad Sci U S A; 2011 Aug; 108(35):14620-5. PubMed ID: 21873245
[TBL] [Abstract][Full Text] [Related]
60. Radiopharmacological evaluation of 6-deoxy-6-[18F]fluoro-D-fructose as a radiotracer for PET imaging of GLUT5 in breast cancer.
Wuest M; Trayner BJ; Grant TN; Jans HS; Mercer JR; Murray D; West FG; McEwan AJ; Wuest F; Cheeseman CI
Nucl Med Biol; 2011 May; 38(4):461-75. PubMed ID: 21531283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
